| dc.contributor.author | Jessica Mooney, Jessica Price, Carolyn Bain, John Tanko Bawa, Nikki Gurley, Amresh Kumar, Guwani Liyanage, Rouden Esau Mkisi, Chris Odero, Karim Seck, Evan Simpson, William P Hausdorff | |
| dc.date.accessioned | 2022-06-29T15:56:59Z | |
| dc.date.available | 2022-06-29T15:56:59Z | |
| dc.date.issued | 2022-06-23 | |
| dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/5308 | |
| dc.description.abstract | Live oral rotavirus vaccines (LORVs) have significantly reduced rotavirus hospitalizations and deaths worldwide. However, LORVs are less effective in low- and middle-income countries (LMICs). Next-generation rotavirus vaccines (NGRVs) may be more effective but require administration by injection or a neonatal oral dose, adding operational complexity. Healthcare providers (HPs) were interviewed to assess rotavirus vaccine preferences and identify delivery issues as part of an NGRV value proposition. | en_US |
| dc.publisher | Public Library of Science | en_US |
| dc.subject | rotavirus vaccines, | en_US |
| dc.title | Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries | en_US |
| dc.type | Article | en_US |
